|
CHECK OUT OUR LATEST ISSUE
Intriguing dermatological products under development or relatively new to the U.S. market include topical and other modified botulinum toxin options, plus new cosmeceutical preparations for the skin and hair.
» Full article
|
|
Discrete changes in the skin, hair and nails could be invaluable evidence in forensic medicine. » Full article
|
|
Although the timeline for implementation of the ICD-10 coding system has been pushed back to October 2015, all dermatologists will have to deal with this eventually. Meaningful Use regulations are also here to stay and will impact every dermatologist. Dermatology Times editorial advisor Norman Levine, M.D., talks with Mark Kaufmann, M.D., associate clinical professor in the department of dermatology at Mount Sinai Medical School in New York, about these initiatives.
» Full article
|
ADVERTISEMENT
Current and emerging therapies for psoriatic arthritis
Symptoms of psoriatic arthritis include inflammation in the joints and excessive production of skin cells. Learn about treatment options to help reduce these symptoms in your patients. View our psoriatic arthritis topic-based resource center and
 Learn More.
|
|
An innovative new line of cosmeceuticals (NuvesseMD, Nuvesse Skin Therapies) is being looked at as an exciting advance in the skincare market.
» Full article
|
|
A recent study suggests that the most important predictive factors of recurrence for nonmelanoma skin cancers (NMSC) following radiotherapy include immunosuppression, age of the patient, tumor size as well as the treatment modality used. » Full article
|
|
|
Don't miss our supplement:
Advances in understanding acne & rosacea
|
|
Like
Tweet
